New radioligand therapy with 177Lu-PSMA-617 in men with metastatic prostate cancer: Initial clinical experience after 50 therapy cycles.
2016 ◽
Vol 34
(15_suppl)
◽
pp. e16575-e16575
2016 ◽
Vol 43
(12)
◽
pp. 835
◽
Keyword(s):
2016 ◽
Vol 41
(7)
◽
pp. 572-573
◽
2015 ◽
Vol 18
(1)
◽
pp. 81-85
◽
2018 ◽
1988 ◽
Vol 37
(3)
◽
pp. 165-167
◽
Keyword(s):